GlobeNewswire
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial
📈
AI Sentiment
Highly Positive
8/10
Latest updates and market news for ELTX
AI Sentiment
Highly Positive
8/10
Share this news page